Avatrombopag: a novel oral therapy for the treatment of ITP

(1:53)

Avatrombopag in patients with early versus chronic immune thrombocytopenia

(1:46)

Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic...

(6:21)

Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic

(6:21)

Doptelet (Avatrombopag)- Thrombocytopenia in adult

(2:24)

Immune Thrombocytopenia (ITP) | Idiopathic Thrombocytopenic Purpura [Updated 2024]

(17:52)

CBOT | Pharmacology | Dr Siraj Ahmad

(30:10)

What has changed in ITP over the last 20 years Professor David Kuter

(26:22)

My Cancer Journey: Lymphoma Symptoms and Diagnosis | My Cancer Story Part 1

(13:32)

Pharmacology -Hematopoietic growth factors

(21:38)

What’s new in ITP Treatment Presentation by Dr Drew Provan

(21:2)

Prof Waleed Ghanima - The problem of Thrombosis in ITP

(18:56)

Platelet count drop causes and treatment || Dr .Karuna Kumar || Consultant Hematologist

(5:42)

Hematinics | Drugs | Darbepoetin alfa, Pegfilgrastim, Sargramostim, Oprelvekin and Avatrombopag

(9:18)

Eltrombopag Vs Romiplostim in ITP | Benefits and Sideeffects | Dr Karuna Kumar | Hematologist

(5:28)

Avatrombopag, rilzabrutinib and COVID-19 updates in ITP

(1:26)

Dr. Fertrin on the FDA Approval of Avatrombopag in ITP

(49)

Avatrombopag following switch from eltrombopag or romiplostim in patients with ITP

(1:10)

Synthesis of Drugs: Avatrombopag

(5:27)

Dr.Gobind Rai Garg discusses the topic - Avatrombopag

(1:52)

Thrombopoietin receptor agonists in ITP: current status and future outlooks

(3:17)

Doptelet Mechanism of Action

(7:24)

Life After Diagnosis

(5:13)

Doptelet: A Lasting Relationship

(31)

The Platelet Couch Featuring Dr Terry Gernsheimer

(14:10)

Say, \

(31)

The Platelet Couch Featuring Dr James Bussel

(12:23)

The Platelet Couch ITP Panel Discussion

(17:1econd)

Letter from America What is the current position with the thrombopoietins Dr Adam Cuker.

(32:56)